Eli Lilly & Co. (LLY) Tops Q4 EPS by 2c; offers outlook
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,102.08 +0.32%
Revenue Growth %: +31.7%
Financial Fact:
Net income: 778M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +31.7%
Financial Fact:
Net income: 778M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q4 EPS of $5.32, $0.02 better than the analyst estimate of $5.30. Revenue for the quarter came in at $13.53 billion versus the consensus estimate of $13.78 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2025 EPS of $22.50-$24.00, versus the consensus of $22.69. Eli Lilly & Co. sees FY2025 revenue of $58-61 billion, versus the consensus of $58.91 billion.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
- JPMorgan Starts Nippon Life India Asset Management Ltd (NAM:IN) at Overweight
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
